Bloodjournal is a scientific publishing platform focused on hematology research, with a narrow product footprint centered on its journal management and online submission systems. Current exploitation activity, severity distribution, and exposure counts are shown alongside this summary.
The number and severity of CVEs published that impact products developed by Bloodjournal over time
Signals from CVEs in this vendor scope (1 CVEs).
1 CVEs · Highest risk first
| CVE | Published | CVSS | Risk | KEV | Exploit |
|---|---|---|---|---|---|
CVE-2014-7543MEDIUM The Blood (aka com.sheridan.ash) application 2.1 for Android does not verify X.509 certificates from SSL servers, which allows man-in-the-middle attackers to spoof servers and obta | Oct 20, 2014 | 5.4 | 15 | NO | NO |
Signals from CVEs in this vendor scope (1 CVEs).
An overview of all social media posts that mention a CVE ID that affects a product developed by Bloodjournal.
Media articles that mention a CVE ID that affects a product developed by Bloodjournal — matched by CVE ID, not by vendor name.